Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival

about

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

P2860

Q36608689-5A62CA93-AD6A-4C6C-9260-6906B5A73F6F

P2860

Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival

Item

http://www.wikidata.org/entity/Q36961764

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Second hematopoietic SCT for l ...... ants does not prolong survival

@en

type

Item

label

Second hematopoietic SCT for l ...... ants does not prolong survival

@en

prefLabel

Second hematopoietic SCT for l ...... ants does not prolong survival

@en

P1476

Second hematopoietic SCT for l ...... ants does not prolong survival

@en

P2093

A John Barrett

http://www.w3.org/2001/XMLSchema#string

E Koklanaris

http://www.w3.org/2001/XMLSchema#string

F Yin

http://www.w3.org/2001/XMLSchema#string

J Haggerty

http://www.w3.org/2001/XMLSchema#string

M Battiwalla

http://www.w3.org/2001/XMLSchema#string

N F Hensel

http://www.w3.org/2001/XMLSchema#string

S Ito

http://www.w3.org/2001/XMLSchema#string

T Hughes

http://www.w3.org/2001/XMLSchema#string

Z A McIver

http://www.w3.org/2001/XMLSchema#string

P2860

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation.

Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.

Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.

Relapse after allogeneic stem cell transplantation

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns.

Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation.

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

Second allogeneic stem cell transplantation in myeloid malignancies.

P2888

bmt.2013.39

P304

1192-1197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2013.39

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236076433

http://www.w3.org/2001/XMLSchema#string

P6179

1008987049

http://www.w3.org/2001/XMLSchema#string

P698

23524640

http://www.w3.org/2001/XMLSchema#string

P932

3695054

http://www.w3.org/2001/XMLSchema#string

Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival

about

P2860

P2860

Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932